Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Feb;60(2):187-93.

Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities

Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities

R F Tiebout et al. Immunology. 1987 Feb.

Abstract

We investigated the requirements for growth of Epstein-Barr virus-transformed cells at low cell densities in a homotypic system: only Epstein-Barr virus-transformed cells or their products were used to supply feeder activity. The cloning efficiency was increased markedly under conditions favouring close cell-to-cell contact: culture in round-bottomed rather than in flat-bottomed wells or the addition of irradiated Epstein-Barr virus-transformed cells. Further enhancement was obtained by the addition of the tumour promoter phorbol-myristate acetate. Part of this effect was also induced by supernatants of Epstein-Barr virus-transformed cells, in particular when the latter had been stimulated with phorbol ester. Thus, under limiting dilution conditions, Epstein-Barr virus-transformed cells were found to be dependent upon autologous cell-mediated and soluble proliferation-stimulating signals. In such a homotypic feeder system, the cloning efficiency could be enhanced up to eight-fold; a 100% cloning efficiency could not be achieved. Evidence is presented that the residual deficit in cloning efficiency is inherent to these cell lines.

PubMed Disclaimer

References

    1. Curr Top Microbiol Immunol. 1978;81:152-5 - PubMed
    1. J Exp Med. 1986 May 1;163(5):1132-49 - PubMed
    1. In Vitro. 1979 Feb;15(2):103-8 - PubMed
    1. N Engl J Med. 1980 Oct 9;303(15):878-80 - PubMed
    1. J Immunol. 1981 Oct;127(4):1275-80 - PubMed

LinkOut - more resources